1853-1862. 2. Ferenci P, Kramer L. MARS and the failing liver Any help from the outer space? HEPATOLOGY 2007;46:1682-1684. 3. Ruiz-del-Arbol L, Monescillo A, Arocena C, Valer P, Gines P, Moreira V, et al. Circulatory function and hepatorenal sı́ndrome in cirrosis. HEPATOLOGY 2005;42: 439-447. 4. Arroyo V, Terra C, Gines P. Advances in the pathogenesis and treatment of type-1 and type-2 hepatorenal syndrome. J Hepatol 2007;46: 935-946. 5. Guevara M, Bru C, Gines P, Fernandez-Esparrach G, Sort P, Bataller R, et al. Increased cerebrovascular resistance in cirrhotic patients with ascites. HEPATOLOGY 1998;28:39-44. 6. Keiding S, Sørensen M, Bender D, Munk OL, Ott P, Vilstrup H. Brain metabolism of 13N-ammonia during acute hepatic encephalopathy in cirrhosis measured by positron emission tomography. HEPATOLOGY 2006;43: 42-50. 7. Fernandez J, Escorsell A, Zabalza M, Felipe V, Navasa M, Mas A, et al. Adrenal insufficiency in patients with cirrosis and septic shock: effect of treatment with hydrocortisone on survival. HEPATOLOGY 2006;44:12881295. 8. Ruiz-del-Arbol L, Uman J, Fernandez J, Gonzalez M, Navasa M, Monescillo A, et al. Systemic, renal and hepatic hemodynamic derangement in cirrhotic patients with spontaneous bacterial peritonitis. HEPATOLOGY 2003;38:1210-1218. 9. Fernandez J, Navasa M, Planas R, Montoliu S, Monfort D, Soriano G, et al. Primary prophylaxis of spontaneous bacterial peritonitis delays hepatorenal syndrome and improves survival in cirrhosis. Gastroenterology 2007; 133:818-824. 10. Schmidt T, Sorensen V, Svendsen L, Hansen B, Larsen FS. Hemodynamic changes during a single treatment with the molecular adsorbents recirculating system in patients with acute-on-chronic liver failure. Liver Transpl 2001;7:1034-1039. 11. Laleman W, Wilmer A, Evenepoel P, Elst IV, Seegers M, Zaman Z, et al. Effect of the molecular adsorbent recirculating system and Prometheus devices on systemic hemodynamics and vasoactive agents in patients with acute-on-chronic alcoholic liver failure. Crit Care 2006;10:R108. 12. Sens S, Mookerjee RP, Cheschire LM, Davies NA, Williams R, Jalan R. Albumin dialysis reduces portal pressure acutely in patients with severe alcoholic hepatitis. J Hepatol 2005;43:142-148.
[1]
L. Kramer,et al.
MARS and the failing liver—Any help from the outer space?
,
2007,
Hepatology.
[2]
M. Navasa,et al.
Primary prophylaxis of spontaneous bacterial peritonitis delays hepatorenal syndrome and improves survival in cirrhosis.
,
2007,
Gastroenterology.
[3]
V. Arroyo,et al.
Advances in the pathogenesis and treatment of type-1 and type-2 hepatorenal syndrome.
,
2007,
Journal of hepatology.
[4]
V. Arroyo,et al.
Adrenal insufficiency in patients with cirrhosis and septic shock: Effect of treatment with hydrocortisone on survival
,
2006,
Hepatology.
[5]
F. Nevens,et al.
Effect of the molecular adsorbent recirculating system and Prometheus devices on systemic haemodynamics and vasoactive agents in patients with acute-on-chronic alcoholic liver failure
,
2006,
Critical care.
[6]
Yasunori Ozawa,et al.
[Iodine-induced hypothyroidism].
,
2006,
Nihon rinsho. Japanese journal of clinical medicine.
[7]
W. Jiménez,et al.
Circulatory function and hepatorenal syndrome in cirrhosis
,
2005,
Hepatology.
[8]
Roger Williams,et al.
Albumin dialysis reduces portal pressure acutely in patients with severe alcoholic hepatitis.
,
2005,
Journal of hepatology.
[9]
W. Jiménez,et al.
Systemic, renal, and hepatic hemodynamic derangement in cirrhotic patients with spontaneous bacterial peritonitis
,
2003,
Hepatology.
[10]
N. Tritos,et al.
Hypothyroidism in two patients after hepatic arterial chemoembolization.
,
2001,
Annals of internal medicine.
[11]
R. Bataller,et al.
Increased cerebrovascular resistance in cirrhotic patients with ascites
,
1998,
Hepatology.
[12]
G. Dusheiko,et al.
Management of hepatocellular carcinoma.
,
1992,
Journal of hepatology.
[13]
J. Wolff,et al.
The inhibitory action of excessive iodide upon the synthesis of diiodotyrosine and of thyroxine in the thyroid gland of the normal rat.
,
1948,
Endocrinology.